Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons from Coley's Toxin.

Kangla Tsung1, Jeffrey A Norton

  • 1Department of Surgery, Stanford University School of Medicine, Room H3591, 300 Pasteur Drive, Stanford, CA 94025, USA.

Surgical Oncology
|July 4, 2006
PubMed
Summary

Coley's Toxin contains interleukin-12 (IL-12) as its active molecule, not tumor necrosis factor (TNF) or lipopolysaccharide (LPS). This discovery offers a new pathway for enhancing anti-tumor immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol to interrogate the role of creeping fat and mechanical tension in Crohn's disease using a surgical mouse model of intestinal fibrosis.

STAR protocols·2026
Same author

A Pan-Cancer Single-Cell Atlas to Evaluate Tumor Identity, Cell Line Concordance, and Dependency Mapping.

bioRxiv : the preprint server for biology·2026
Same author

A Translational Surgical Porcine Model for Postoperative Intra-Abdominal Adhesion Formation.

Journal of visualized experiments : JoVE·2026
Same author

NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Cell reports·2026
Same author

Current Medical Controversies in Zollinger-Ellison Syndrome.

Biomedicines·2025
Same author

Correction: Morgan et al. Precision Medicine: IL-1RA and Pancreatic Cancer Organoids. <i>Biology</i> 2025, <i>14</i>, 604.

Biology·2025

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Coley's Toxin, a historical cancer treatment, has been studied for its active components.
  • Previous research hypothesized tumor necrosis factor (TNF) or endotoxin (LPS) as the primary active agents.

Purpose of the Study:

  • To identify the specific active molecule within Coley's Toxin responsible for its anti-tumor effects.
  • To elucidate the mechanism by which Coley's Toxin modulates the immune system against tumors.

Main Methods:

  • Molecular analysis of Coley's Toxin components.
  • Immunoassays to determine the biological activity of isolated molecules.
  • In vitro and in vivo studies to assess anti-tumor immune response.

Main Results:

  • The study identified interleukin-12 (IL-12) as the principal active molecule in Coley's Toxin.
  • Results indicate that IL-12, not TNF or LPS, is responsible for the observed anti-tumor immune modulation.
  • IL-12 was shown to significantly enhance anti-tumor immune responses.

Conclusions:

  • Interleukin-12 (IL-12) is the key active component of Coley's Toxin.
  • Targeting IL-12 presents a promising strategy for developing novel cancer immunotherapies.
  • Understanding the role of IL-12 can lead to improved treatments for various cancers.

Related Experiment Videos